Skip to main content
Top
Published in: Reactions Weekly 1/2012

01-03-2012 | Case report

Trastuzumab

Renal insufficiency following in utero exposure: case report

Published in: Reactions Weekly | Issue 1/2012

Login to get access

Excerpt

An event is serious (FDA MedWatch definition) when the patient outcome is:
  • death
  • life-threatening
  • hospitalisation
  • disability
  • congenital anomaly
  • requires intervention to prevent permanent impairment or damage
Literature
1.
go back to reference Gottschalk I, Berg C, Harbeck N, Stressig R, Kozlowski P.Fetal renal insufficiency following trastuzumab treatment for breast cancer in pregnancy: Case report und review of the current literature. Breast Care 6: 475-478, No. 6, Dec 2011. Available from: URL: http://dx.doi.org/10.1159/000335202 - Germany Gottschalk I, Berg C, Harbeck N, Stressig R, Kozlowski P.Fetal renal insufficiency following trastuzumab treatment for breast cancer in pregnancy: Case report und review of the current literature. Breast Care 6: 475-478, No. 6, Dec 2011. Available from: URL: http://​dx.​doi.​org/​10.​1159/​000335202 - Germany
Metadata
Title
Trastuzumab
Renal insufficiency following in utero exposure: case report
Publication date
01-03-2012
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2012
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-201213920-00152

Other articles of this Issue 1/2012

Reactions Weekly 1/2012 Go to the issue

Case report

Trihexyphenidyl

Case report

Losartan

Case report

Mexiletine

Case report

Lacosamide

Case report

Colecalciferol